These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


182 related items for PubMed ID: 4292904

  • 1. Studies on the antiviral activity of formycin.
    Ishida N, Homma M, Kumagai K, Shimizu Y, Matsumoto S.
    J Antibiot (Tokyo); 1967 Jan; 20(1):49-52. PubMed ID: 4292904
    [No Abstract] [Full Text] [Related]

  • 2. Studies on antiviral activity of virothricin.
    Küchler C, Küchler W.
    Acta Virol; 1966 May; 10(3):195-9. PubMed ID: 4381330
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Antiviral action of gliotoxin.
    McDougall JK.
    Arch Gesamte Virusforsch; 1969 May; 27(2):255-67. PubMed ID: 4313024
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Antiviral action of carbonyl-conjugated pentaene macrolides].
    Shneĭder MA, Shtil'bans EB, Rachkovskaia LA, Poltorak VA.
    Antibiotiki; 1983 May; 28(5):352-7. PubMed ID: 6309075
    [Abstract] [Full Text] [Related]

  • 9. Antiviral effect of methylglyoxal-bis-guanylhydrazone.
    Küchler C, Küchler W, Schulze W.
    Acta Virol; 1968 Sep; 12(5):441-5. PubMed ID: 4386637
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Antiviral activity of some guanylhydrazone derivatives].
    Loddo B, Gessa GL, Schivo ML, Nakamura Y.
    Boll Soc Ital Biol Sper; 1965 Jun 30; 41(12):633-6. PubMed ID: 4291468
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. R75761, a lead compound for the development of antiviral drugs in late stage poliomyelitis eradication strategies and beyond.
    Thys B, De Palma AM, Neyts J, Andries K, Vrijsen R, Rombaut B.
    Antiviral Res; 2008 Jun 30; 78(3):278-81. PubMed ID: 18294707
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.